Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

  1. Olaso, E.
  2. Vidal-Vanaclocha, F.
Revista:
Methods in molecular medicine

ISSN: 1543-1894

Any de publicació: 2003

Volum: 85

Pàgines: 79-86

Tipus: Revisió

DOI: 10.1385/1-59259-380-1:79 GOOGLE SCHOLAR